Objective To investigate clinical diagnosis,timing of surgery and perioperative therapeutic strategies for blood culture-negative infective endocarditis (IE). Methods Clinical data of 240 IE patients who were admitted tWuhan Asia Heart Hospital between July 2008 and July 2012 were retrospectively analyzed. According to their blood cultureresults,all the patients were divided into blood culture-negative group and blood culture-positive group. In the blood culture-negative group,there were 158 patients including 88 male and 70 female patients with their age of 51.3±10.1 years. In the blood culture-positive group,there were 82 patients including 45 male and 37 female patients with their age of 48.9±9.8 years. All the patients underwent surgical treatment,and the surgical procedures included complete vegetations excision,debridement of infected valves,removal of necrotic tissue around the annulus,and concomitant heart valve replacement or intracardiac repair. Postoperatively,all the patients received routine monitoring in ICU,cardiac glycosides,diuretics,other symptomatic treatment and adequate dosages of antibiotics for 4-6 weeks. Results Four patients died postoperatively in this study including 1 patient for low cardiac output syndrome and 3 patients for multiple organ dysfunction syndrome,1 patient in the blood culture-positive group and 3 patients in the blood culture-negative group respectively. There was no statistical difference in surgical mortality between the 2 groups (χ2=0.15,P=0.70). All the other patients were discharged successfully and followed up for 6 to 36 months with the median follow-up time of 22 months. During follow-up, 2 patients died including 1 patient for cerebral infarction 2 years after surgery and another patient for cerebral hemorrhage 3 yearsafter surgery. Conclusion Patients with blood culture-negative IE should receive adequate dosage and duration of broad-spectrum antibiotics to control the infection rapidly, and aggressive surgical therapy to decrease in-hospital mortality and improve their quality of life and prognosis.
Abstract:?Objective?To analyze surgical procedures and clinical outcomes for patients with hypertrophic obstructive cardiomyopathy (HOCM) complicated by infective endocarditis.?Methods?We retrospectively analyzed clinical data of 7 patients with HOCM complicated by infective endocarditis who underwent modified Morrow procedure,removal of intracardiac vegetation,and valve replacement in Fu Wai Hospital from Sep. 2006 to Feb. 2012. There were 5 male patients and 2 female patients with their mean age of 39.80±13.60 years(ranging 21-55). Postoperative clinical outcomes were observed. Preoperative and postoperative left ventricular outflow tract (LVOT) gradients, left atrium (LA) diameter,left ventricular ejection fraction (LVEF) and heart function were compared.?Results?There was no in-hospital death and perioperative survival rate was 100% in this group. Bacteria vegetations were multiply detected on the mitral valve leaflet (7 cases), aortic valve leaflet (4 cases) and ventricular septum (1 case) with their diameter of 2-19 mm. Blood culture showed Staphylococcus aureus (3 cases),Squirrel aureus (1 case) . Postoperatively, first-degree atrioventricular block occurred in 2 patients, complete left bundle branch block in 1 patient, left anterior division block in 2 patients, and all these complications were not treated. Postoperative LVOT gradient and LA diameter were significantly lower than preoperative values (P<0.05), and cardiac function was significantly improved in these patients. All the patients underwent transthoracic echocardiography at a mean follow-up of 13.00±17.19 (1-49) months in outpatient service. The clinical symptoms of all these patients were diminished or significantly ameliorated and their quality of life was considerably improved. All the patients had NYHA classⅠorⅡ without any reintervention or death during follow-up.?Conclusion?Modified Morrow procedure and valve replacement is a good surgical strategy for patients with HOCM complicated by infective endocarditis with satisfactory early and mid-term clinical outcomes.